Tacrolimus in combination, tacrolimus alone compared (TICTAC trial): a prospective randomized trial of minimized immunosuppression in adult heart transplant recipients

Trial Profile

Tacrolimus in combination, tacrolimus alone compared (TICTAC trial): a prospective randomized trial of minimized immunosuppression in adult heart transplant recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2015

At a glance

  • Drugs Tacrolimus (Primary) ; Corticosteroids; Mycophenolate mofetil
  • Indications Heart transplant rejection
  • Focus Pharmacodynamics
  • Acronyms TICTAC
  • Most Recent Events

    • 27 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 25 Apr 2013 Results of an analysis on the incidence of malignancy presented at the 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 07 Jan 2011 Results published in Circulation: Heart Failure.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top